2012
|
Invention
|
Biological products.
There is disclosed antibody molecules containing at least one CDR derived f... |
2010
|
Invention
|
Novel pharmaceutical compositions comprising levetiracetam.
The present invention relates to a p... |
2007
|
Invention
|
Compositions and methods for increasing bone mineralization.
A novel class or family of TGF-β bi... |
|
Invention
|
Compositions and methods for increasing bone mineralization. A novel class or family of TGF-β bin... |
|
Invention
|
Tablet comprising efletirizine and pseudoephedrine.
The present invention concerns a tablet comp... |
2006
|
Invention
|
2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and... |
|
Invention
|
Mast cell activation using siglec 6 antibodies.
The present invention provides a method of modul... |
|
Invention
|
Mouse primers. The present invention provides primer sets for the isolation of mouse antibody var... |
|
Invention
|
Pig primers. The present invention provides primer sets for the isolation of pig antibody variabl... |
|
Invention
|
Rat primers. The present invention provides primer sets for the isolation of rat antibody variabl... |
|
Invention
|
Sheep primers. The present invention provides primer sets for the isolation of sheep antibody var... |
2005
|
Invention
|
Indolone derivatives, processes for preparing them and their uses. The present invention relates ... |
|
Invention
|
Multiple active drug-resin conjugate. A combination pharmaceutical preparation including two diff... |
|
Invention
|
Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation. The present i... |
|
Invention
|
Benzoxazolone derivatives, processes for preparing them and their uses. The present invention rel... |
2004
|
Invention
|
Imidazole derivatives, processes for preparing them and their uses. The present invention relates... |
|
Invention
|
Process for preparing 2-oxo-1-pyrrolidine derivatives. The present invention relates to a new pro... |
|
Invention
|
Improved process for supported phase synthesis. The present invention relates to an improved proc... |
|
Invention
|
Use of efletirizine for treating persistent allergic rhinitis.
The present invention relates to ... |
|
Invention
|
Authentication means. There is described a two part means of authenticating a polymeric film wher... |
|
Invention
|
Authentication means. There is described a biaxially oriented polypropylene (BOPP) film which has... |
|
Invention
|
Removable pressure sensitive adhesives with plasticizer resistance properties. A removable, plast... |
|
Invention
|
Indolone-acetamide derivatives, processes for preparing them and their uses. The present inventio... |
|
Invention
|
Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug. The present invention relat... |
|
Invention
|
Deodorizing agent for sulfur-or nitrogen-containing initiators. Cationic initiator compositions f... |
|
Invention
|
Method of forming heat resistant raised print from radiation curable solid particulate compositio... |
|
Invention
|
Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic a... |
|
Invention
|
Piperazine derivatives and their use as synthesis intermediates. The present invention relates to... |
|
Invention
|
Hydrogenation catalysts. A catalyst comprising a chiral transition metal-(1,2-bis(2,5-dialkylphos... |
|
Invention
|
Hydrogenation catalysts. A catalyst comprising a chiral transition metal-(1,2-bis(2,5- dialkylpho... |
2003
|
Invention
|
Pyrrolidinone derivatives. The present invention provides pharmaceutical compositions and novel c... |
|
Invention
|
Methods for the identification of agents for the treatment of seizures, neurological diseases, en... |
|
Invention
|
Methods for identifying agents that bind a levetiracetam binding site (lbs) or compete with lev b... |
|
Invention
|
Tablet comprising efletirizine and pseudoephedrine. The present invention concerns a tablet compr... |
|
Invention
|
Chemical compounds with dual activity, processes for their preparation and pharmaceutical composi... |
|
Invention
|
Pharmaceutical formulations with modified release.
The invention relates to a pharmaceutical com... |
2002
|
Invention
|
Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic r... |
|
Invention
|
Pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders. A use of ... |
|
Invention
|
Analgesic combination of muscarinic agonists. This invention relates to the combination of muscar... |
|
Invention
|
Compounds and methods for treatment of asthma, allergy and inflammatory disorders. The present in... |
2000
|
Invention
|
Antibodies associated with alterations in bone density. Compositions and methods for increasing b... |